Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.45
0.10 (2.30%)
At close: Aug 15, 2025, 10:05 AM
Monte Rosa Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 177.99M | 159.49M | 75.62M | 23.73M | 14.51M | 9.82M | 8.75M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 6.29M | 6.22M | 8.12M | 7.91M | 7.64M | 6.97M | 6.22M | 7.06M | 7.8M | 8.58M | 8.56M | 6.69M | 4.69M | 2.99M | 2.13M | 1.32M | 741K | 274K |
Gross Profit | 171.7M | 153.26M | 67.5M | 9.17M | -1.88M | -5.9M | -6.22M | -7.06M | -7.8M | -8.58M | -8.56M | -6.69M | -4.69M | -2.99M | -2.13M | -1.32M | -741K | -274K |
Operating Income | 14.96M | -2.13M | -81.11M | -128.98M | -139.42M | -144M | -143.31M | -140.94M | -132.33M | -122.34M | -112.38M | -103.28M | -94.79M | -85.68M | -72.88M | -61.43M | -47.95M | -35.22M |
Interest Income | 11.99M | 11.56M | 10.57M | 10.34M | 9.67M | 9.34M | 9.33M | 8.96M | 7.73M | 6.05M | 3.76M | 1.79M | 803K | 189K | 46K | 42K | 31K | 18K |
Pretax Income | 28.42M | 9.46M | -70.13M | -119M | -129.93M | -134.86M | -135.01M | -132.52M | -125.13M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.96M | -70.17M | -56.9M | -43.85M |
Net Income | 24.17M | 6.15M | -72.7M | -119.39M | -130.41M | -135.28M | -133.13M | -128.95M | -120.34M | -110.87M | -104.62M | -98.98M | -92.55M | -85.24M | -73.96M | -70.17M | -56.9M | -43.85M |
Selling & General & Admin | 33.7M | 34.89M | 35.17M | 34.12M | 34.66M | 33.52M | 32.04M | 31.93M | 30.29M | 28.44M | 27.32M | 24.96M | 22.69M | 19.88M | 15.73M | 12.54M | 8.7M | 5.76M |
Research & Development | 127.26M | 122.61M | 115.55M | 104.03M | 104.72M | 107.8M | 109.43M | 109M | 102.04M | 93.9M | 85.06M | 78.32M | 72.1M | 65.8M | 57.16M | 48.89M | 39.24M | 29.46M |
Other Expenses | -2.1M | -2.1M | -2.1M | n/a | -1.83M | -1.83M | -1.83M | -1.83M | n/a | n/a | n/a | n/a | n/a | n/a | -960K | -960K | -960K | -960K |
Operating Expenses | 158.86M | 155.39M | 148.61M | 138.15M | 137.54M | 139.49M | 139.63M | 139.1M | 132.33M | 122.34M | 112.38M | 103.28M | 94.79M | 85.68M | 72.88M | 61.43M | 47.95M | 35.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9K | 9K | 9K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 163.03M | 161.62M | 156.73M | 143.95M | 145.18M | 145.06M | 143.31M | 140.94M | 132.33M | 122.34M | 112.38M | 103.28M | 94.79M | 85.68M | 72.88M | 61.43M | 47.95M | 35.22M |
Income Tax Expense | 4.26M | 3.31M | 2.57M | 384K | 143K | 81K | -2.22M | -3.91M | -4.78M | -5.73M | -3.88M | -2.18M | -1.13M | -370K | n/a | 40K | 40K | 8K |
Shares Outstanding (Basic) | 82.19M | 82.15M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 5.07M | 42.54M |
Shares Outstanding (Diluted) | 82.19M | 82.96M | 61.44M | 82.01M | 71.23M | 60.16M | 56.93M | 49.81M | 49.43M | 49.35M | 48.89M | 46.73M | 46.67M | 46.6M | 45.99M | 45.99M | 5.07M | 42.54M |
EPS (Basic) | 0.35 | 0.07 | -1.03 | -1.83 | -2.24 | -2.52 | -2.59 | -2.6 | -2.46 | -2.3 | -2.21 | -2.13 | -2 | -5.08 | -4.86 | -5.25 | -5.12 | -1.74 |
EPS (Diluted) | 0.35 | 0.07 | -1.03 | -1.83 | -2.24 | -2.52 | -2.59 | -2.6 | -2.46 | -2.3 | -2.21 | -2.13 | -2 | -5.08 | -4.86 | -5.25 | -5.12 | -1.74 |
EBITDA | 21.17M | 6.14M | -72.99M | -121.07M | -131.78M | -137.03M | -137.09M | -135.49M | -127.69M | -118.2M | -108.64M | -99.8M | -91.75M | -83.07M | -70.75M | -59.88M | -46.81M | -34.48M |
EBIT | 19.42M | -2.13M | -81.11M | -128.98M | -139.42M | -144M | -143.31M | -140.94M | -132.33M | -122.34M | -112.38M | -103.28M | -94.79M | -85.68M | -72.88M | -61.43M | -47.95M | -35.22M |
Depreciation & Amortization | 8.34M | 8.27M | 8.12M | 7.91M | 7.64M | 6.97M | 6.22M | 7.06M | 7.8M | 8.58M | 8.56M | 6.69M | 4.69M | 2.99M | 2.13M | 1.55M | 1.14M | 740K |